More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...